Your browser doesn't support javascript.
loading
Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn's disease.
Liefferinckx, Claire; Hubert, Antoine; Thomas, Debby; Bottieau, Jérémie; Minsart, Charlotte; Cremer, Anneline; Amininejad, Leila; Vallée, François; Toubeau, Jean-François; Franchimont, Denis.
Afiliación
  • Liefferinckx C; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Route de Lennik 808, Brussels 1070, Belgium; Department of Gastroenterology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: Claire.liefferinckx@erasme.ulb.ac.be.
  • Hubert A; Department of Electrical Engineering, University of Mons, Mons, Belgium.
  • Thomas D; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Bottieau J; Department of Electrical Engineering, University of Mons, Mons, Belgium.
  • Minsart C; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Route de Lennik 808, Brussels 1070, Belgium; Department of Gastroenterology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Cremer A; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Route de Lennik 808, Brussels 1070, Belgium; Department of Gastroenterology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Amininejad L; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Route de Lennik 808, Brussels 1070, Belgium; Department of Gastroenterology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
  • Vallée F; Department of Electrical Engineering, University of Mons, Mons, Belgium.
  • Toubeau JF; Department of Electrical Engineering, University of Mons, Mons, Belgium.
  • Franchimont D; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Route de Lennik 808, Brussels 1070, Belgium; Department of Gastroenterology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Dig Liver Dis ; 55(3): 366-372, 2023 Mar.
Article en En | MEDLINE | ID: mdl-35977875
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Ustekinumab Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Dig Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article